MediMabBio
A biotechnology company that focuses on developing new therapeutic drugs targeting Oncology and Inflammatory Disease
15 employees · est. 2017 · Korea South
Nexo Therapeutics
We’re driven to translate the most compelling and still undrugged targets in human biology into medicines for patients
19 employees · est. 2022 · Watertown, United States
MediMabBio is the older company (2017 vs 2022).
Side-by-Side Comparison
| Metric | MediMabBio | Nexo Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2022 |
| Headquarters | ||
| Headquarters | Korea South | Watertown, United States |
| Employees | ||
| Employees | 15 | 19 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Non Equity Assistance | Series A |
| Total Funding | ||
| Total Funding | Not tracked yet | $60.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 1 |
| Services | ||
| Services | Not tracked yet | Chemical Biology R&D, Covalent Drug Design, Biomedical Research, Biotech Innovations |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotech Researchers, Healthcare Institutions, Drug Development Firms |
| Taxonomy | ||
| Taxonomy | Therapeutic Drugs, Oncology, Inflammatory Disease, Immunotherapy, Cancer Treatment, Systems Biology, Immunological Solutions, Novel Drugs, Immuno-oncology, Antibody Discovery, R&D Collaborations, Academic Partnerships, Solid Tumors, Drug Development | Oncology, Cancer Therapy, Small Molecule Drugs, Covalent Ligand Discovery, Chemical Biology, Cancer Biology, Medicinal Chemistry, Drug Discovery, Biopharmaceutical, Precision Medicine, Innovation, Scientific Expertise, Clinical Trials |
| Website | ||
| Website | medimabbio.com | nexotx.com |
About MediMabBio
MediMabBio is a biotechnology company founded in 2017, with its headquarters in Korea South. The company's slogan emphasizes its focus on developing new therapeutic drugs targeting Oncology and Inflammatory Disease. MediMabBio is dedicated to the generation of novel immunotherapies for the treatment...
About Nexo Therapeutics
Nexo Therapeutics, founded in 2022, is a dynamic player in the Biotechnology and Life Sciences industries, based in the United States. The company is committed to creating innovative small molecule therapies targeting cancer, particularly for patients lacking substantial treatment options. This alig...
We will tell you when either one moves
BounceWatch watches MediMabBio and Nexo Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at MediMabBio and Nexo Therapeutics — by email.
Frequently Asked Questions
Compare MediMabBio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at MediMabBio on 15 Sep 2024, and Nexo Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.